Nascent Biotech Management
Management criteria checks 4/4
Nascent Biotech's El consejero delegado es Sean Carrick , nombrado en Mar 2015, tiene un mandato de 8.75 años. la remuneración anual total es $252.00K , compuesta por 100% salario y 0% primas, incluidas acciones y opciones de la empresa. posee directamente 13.45% de las acciones de la empresa, por valor de $4.49M . La antigüedad media del equipo directivo y del consejo de administración es de 8.8 años y 8.4 años respectivamente.
Key information
Sean Carrick
Chief executive officer
US$252.0k
Total compensation
| CEO salary percentage | 100.0% |
| CEO tenure | 9.1yrs |
| CEO ownership | 13.3% |
| Management average tenure | 9.1yrs |
| Board average tenure | 8.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$2m |
| Sep 30 2023 | n/a | n/a | -US$3m |
| Jun 30 2023 | n/a | n/a | -US$2m |
| Mar 31 2023 | US$252k | US$252k | -US$3m |
| Dec 31 2022 | n/a | n/a | -US$3m |
| Sep 30 2022 | n/a | n/a | -US$1m |
| Jun 30 2022 | n/a | n/a | -US$1m |
| Mar 31 2022 | US$252k | US$252k | -US$470k |
| Dec 31 2021 | n/a | n/a | US$319k |
| Sep 30 2021 | n/a | n/a | -US$998k |
| Jun 30 2021 | n/a | n/a | -US$1m |
| Mar 31 2021 | US$352k | US$252k | -US$959k |
| Dec 31 2020 | n/a | n/a | -US$4m |
| Sep 30 2020 | n/a | n/a | -US$4m |
| Jun 30 2020 | n/a | n/a | -US$4m |
| Mar 31 2020 | US$323k | US$250k | -US$4m |
| Dec 31 2019 | n/a | n/a | -US$1m |
| Sep 30 2019 | n/a | n/a | -US$1m |
| Jun 30 2019 | n/a | n/a | -US$1m |
| Mar 31 2019 | US$262k | US$186k | -US$1m |
| Dec 31 2018 | n/a | n/a | -US$2m |
| Sep 30 2018 | n/a | n/a | -US$2m |
| Jun 30 2018 | n/a | n/a | -US$2m |
| Mar 31 2018 | US$151k | US$151k | -US$2m |
Compensación vs. Mercado: Sean($USD252.00K) está por debajo de la media de empresas de tamaño similar en el mercado US ($USD740.57K).
Compensación vs. Ingresos: La compensación de Sean ha sido consistente con los resultados de la empresa en el último año.
CEO
Sean Carrick (55 yo)
9.1yrs
Tenure
US$252,000
Compensation
Mr. Sean Carrick has been the President of Nascent Biotech, Inc. since March 9, 2015 and serves as its Chief Executive Officer and Secretary. Mr. Carrick has been Director of Nascent Biotech, Inc. since Ju...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 9.1yrs | US$252.00k | 13.34% $ 3.9m | |
| CFO, Chief Accounting Officer & Director | 9.9yrs | US$180.00k | 6.93% $ 2.0m | |
| Founder | no data | US$43.00k | no data | |
| Chief Medical Consultant | 3.8yrs | no data | no data |
9.1yrs
Average Tenure
71yo
Average Age
Equipo directivo experimentado: NBIOEl equipo directivo de la empresa es veterano y experimentado (8.8 años de antigüedad media).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 9.8yrs | US$252.00k | 13.34% $ 3.9m | |
| CFO, Chief Accounting Officer & Director | 9.8yrs | US$180.00k | 6.93% $ 2.0m | |
| Member of Scientific Advisory Board | 8.8yrs | no data | no data | |
| Independent Director | 8yrs | US$20.00k | 1.02% $ 297.2k | |
| Member of Scientific Advisory Board | 8.8yrs | no data | no data | |
| Member of Scientific Advisory Board | 1.3yrs | no data | no data |
8.8yrs
Average Tenure
58yo
Average Age
Junta con experiencia: La junta directiva de NBIO se considera experimentada (8.4 años de antigüedad promedio).